1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014

Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • Global Data
  • -
  • 64 pages

Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Cedar Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cedar Pollen Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cedar Pollen Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cedar Pollen Allergy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Cedar Pollen Allergy to Immunology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of Cedar Pollen Allergy 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Cedar Pollen Allergy Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Japan Tobacco Inc. 25
Clinical Trial Overview of Japan Tobacco Inc. 25
Otsuka Holdings Co., Ltd. 26
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 26
Immunomic Therapeutics, Inc. 27
Clinical Trial Overview of Immunomic Therapeutics, Inc. 27
Daiichi Sankyo Company, Limited 28
Clinical Trial Overview of Daiichi Sankyo Company, Limited 28
Valeant Pharmaceuticals International, Inc. 29
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 29
Shionogi and Co., Ltd. 30
Clinical Trial Overview of Shionogi and Co., Ltd. 30
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
Johnson and Johnson 32
Clinical Trial Overview of Johnson and Johnson 32
FAES Farma SA 33
Clinical Trial Overview of FAES Farma SA 33
Actelion Ltd 34
Clinical Trial Overview of Actelion Ltd 34
Clinical Trial Overview of Top Institutes / Government 35
Chiba University 35
Clinical Trial Overview of Chiba University 35
University of Yamanashi 36
Clinical Trial Overview of University of Yamanashi 36
Nippon Medical School Hospital 37
Clinical Trial Overview of Nippon Medical School Hospital 37
The University of Tokushima 38
Clinical Trial Overview of The University of Tokushima 38
Jikei University School of Medicine 39
Clinical Trial Overview of Jikei University School of Medicine 39
University of Fukui 40
Clinical Trial Overview of University of Fukui 40
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 41
Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 41
Samoncho Clinic 42
Clinical Trial Overview of Samoncho Clinic 42
Okayama University 43
Clinical Trial Overview of Okayama University 43
Shiga University of Medical Science 44
Clinical Trial Overview of Shiga University of Medical Science 44
Five Key Clinical Profiles 45
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 64

List of Tables
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cedar Pollen Allergy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Cedar Pollen Allergy Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Cedar Pollen Allergy to Immunology Clinical Trials, G7 Countries (%), 2014* 12
Cedar Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Cedar Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Cedar Pollen Allergy Therapeutics, Global, Suspended Clinical Trials, 2014* 19
Cedar Pollen Allergy Therapeutics, Global, Terminated Clinical Trials, 2014* 19
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Cedar Pollen Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Tobacco Inc., 2014* 25
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 26
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunomic Therapeutics, Inc., 2014* 27
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 28
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2014* 29
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi and Co., Ltd., 2014* 30
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 31
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 32
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by FAES Farma SA, 2014* 33
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 34
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2014* 35
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Yamanashi, 2014* 36
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Medical School Hospital, 2014* 37
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokushima, 2014* 38
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Jikei University School of Medicine, 2014* 39
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Fukui, 2014* 40
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2014* 41
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Samoncho Clinic, 2014* 42
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2014* 43
Cedar Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiga University of Medical Science, 2014* 44

List of Figures
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Proportion of Cedar Pollen Allergy to Immunology Clinical Trials, G7 Countries (%), 2014* 12
Cedar Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Cedar Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Cedar Pollen Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Cedar Pollen Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Cedar Pollen Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 63

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.